WestEnd Advisors’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AGN
LP
WestEnd Advisors's AGN Position: Q1 2019 in Review
WestEnd Advisors sold out of Allergan plc (AGN) in Q1 2019, closing a stake of 45 shares — an estimated $6.01K sold.
WestEnd Advisors first reported a position in AGN in Q3 2015 and held it in 14 quarters. The position peaked at $113M in Q4 2015. 991 funds tracked by Wall St. Rank hold AGN as of Q1 2019.
- WestEnd Advisors reported no remaining Allergan plc position as of Q1 2019 after selling out during the quarter.
- WestEnd Advisors sold 45 Allergan plc shares in Q1 2019, an estimated $6.01K.
- WestEnd Advisors first reported a position in Allergan plc in Q3 2015 and held it in 14 quarters.
- WestEnd Advisors's Allergan plc position peaked at $113M in Q4 2015.
- 991 funds tracked by Wall St. Rank held Allergan plc as of Q1 2019.
Based on WestEnd Advisors's 13F filing for Q1 2019, filed 3 May 2019.